drugset / Trial / NCT05266040

Valacyclovir in Pain Management of Acute Apical Abscesses

NCT05266040

Phase 2 Recruiting 60 enrolled University of California, San Francisco
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Virus in Endodontics (VE) phase I pilot study for preoperative pain will be analyzed and adjusted for the Phase II clinical trial. The Phase II clinical trial on preoperative pain, postoperative pain, and clinical healing will involve 250 patients. Patients will be recruited from the same pool of participants as the Phase II clinical trial. Preoperative cone beam computed tomography (CBCT) scans will be taken as well as three and six month postoperative CBCT scans. The secondary outcomes form the Phase II randomized clinical trial will be clinical success and visible radiographic healing determined by CBCT images.

Timeline

Start
2023-10-25
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown 500 mg
Background Amoxicillin Other / unclassified 500 mg